Status:
COMPLETED
Dose Ranging Study
Lead Sponsor:
Neothetics, Inc
Conditions:
Periumbilical Subcutaneous Adipose Tissue Reduction
Eligibility:
All Genders
18+ years
Phase:
PHASE2
Brief Summary
Dose Ranging Study
Eligibility Criteria
Inclusion
- \>18 years of age inclusive Subcutaneous fat in the periumbilical area BMI \<30 kg/msq Stable diet and exercise and body weight
Exclusion
- Prior treatment of subcutaneous fat in the periumbilical area (liposuction, abdominoplasty, etc.) Known hypersensitivity to drugs
Key Trial Info
Start Date :
February 1 2013
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
October 1 2013
Estimated Enrollment :
472 Patients enrolled
Trial Details
Trial ID
NCT01802723
Start Date
February 1 2013
End Date
October 1 2013
Last Update
March 26 2015
Active Locations (22)
Enter a location and click search to find clinical trials sorted by distance.
1
United States, California
Beverly Hills, California, United States
2
United States, California
Encinitas, California, United States
3
United States, California
Los Angeles, California, United States
4
United States, California
San Diego, California, United States